OPEN//Egyptian amb. in Bamako delivers medical aid shipment to Luxembourg Maternity, Childhood Hospital in Mali
In a speech delivered on this occasion Sunday, the Egyptian ambassador to Mali said the medical assistance was announced by Egyptian Minister of Foreign Affairs, Immigration and Egyptian Expatriates Bader Abdelatty when he received Malian Foreign Minister Abdoulaye Diop in Egypt last December.
Gammal said the step comes within the framework of ongoing cooperation between the two countries in the various fields, reflecting the momentum witnessed in bilateral relations.
The Egyptian ambassador reviewed Egypt's role in supporting the development process in Mali, as well as keenness of Egypt on providing support to the government and people of Mali based on a firm belief in the importance of developmental action; being a key axis of achieving prosperity and stability in the African continent.
He noted that the medical shipment provided to the hospital's 'Egyptian wing' is meant to convey a message of pride and appreciation of longstanding Egyptian-Malian relations, and an immediate response to meet the hospital's needs.
In this context, the secretary general of the Malian Ministry of Health, the director general of the Luxembourg Maternity and Childhood Hospital and the director general of the Amadou Toumani Touré Foundation headed by the wife of the former president of Mali delivered speeches praising depth of distinguished Egyptian-Malian relations and expressing sincere appreciation of the shipment of medical aid presented by Egypt, underlining the high contribution of the delivered medical assistance in providing treatment for patients.
They also pointed out that Egypt's cooperation is not new, highlighting
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Middle East
a day ago
- Middle East
OPEN// TV BRICS: UAE donates medical equipment to Zimbabwe to strengthen emergency care
ABU DHABI, July 18 (MENA) - The UAE has donated medical equipment worth dlrs 700,000 to Zimbabwe, bolstering the country's emergency-care capabilities and saving lives nationwide, TV BRICS reported. The donation, which includes 74 ICU ventilators and 34 tons of essential medical supplies, was officially handed over in Harare. The handover ceremony was attended by the Deputy Minister of Health and Child Care of Zimbabwe, Sleiman Kwidini, and the UAE Ambassador to Zimbabwe, Jassim Mohamed Al-Hassanini. The aid comes at a time when Zimbabwe is modernizing its healthcare system. Kwidini noted that the equipment will provide significant assistance to patients with life-threatening conditions. Hassanini reaffirmed the UAE's ongoing commitment to Zimbabwe through development and humanitarian cooperation. "We hope this medical assistance will have a positive impact on the lives of Zimbabweans," he said. Health experts anticipate that the new ICU ventilators will significantly improve survival rates in intensive-care units across the country. (MENA) R R N/
Daily News Egypt
2 days ago
- Daily News Egypt
Sandoz Egypt introduces OMNITROPE 15mg biosimilar growth hormone for the treatment of short stature
Sandoz the global leader in generic and biosimilar medicines, announced the introduction of its 15mg/1.5ml concentration of the OMNITROPE biosimilar growth hormone for the treatment of short stature to the Egyptian market, as part of its ongoing efforts to support Egypt's Vision 2030. Local healthcare authorities remain committed to addressing various health challenges to enhance public health for current and future generations, and help build a healthier, more productive workforce. Research conducted at the Suez Canal University endocrinology outpatient clinic in Ismailia City, Egypt and released in 2024, underscored the importance of short stature treatment, with findings indicating that treatment with growth hormone significantly improved physical, social, psychological, and environmental quality of life¹. 'In children and adolescents, growth hormone is used to treat growth disturbance due to insufficient secretion of growth hormone, associated with Turner syndrome, with chronic renal insufficiency, in short children/adolescents born small for gestational age, or associated with Prader-Willi syndrome (PWS). The biosynthetic/synthetic hormone is indicated for the treatment of children with growth failure due to inadequate secretion of endogenous growth hormone (GH)² ³,' Dr. Mona Salem, Professor of Paediatric Endocrinology at Ain Shams University and President of the Egyptian Society of Paediatric Endocrinology & Diabetes, said. 'Short stature is diagnosed in children or adolescents who are well below the average height for their age and gender, which may be due to genetic factors or underlying health conditions⁴ ⁵. Studies show that short stature prevalence varies geographically, with a genetic predisposition, as well as nutritional and environmental factors, playing an important role⁶,' Dr Salem added. A cross-sectional study conducted between January 2018 and January 2020 involving 33,150 Egyptian children aged 6 to 11 showed that 17% of the sample had short stature, with 40.8% attributed to familial factors and 24.2% to constitutional causes⁷. 'As noted, short stature affects children and adolescents, not only physically but also psychologically' Dr. Rasha Tarif, Head of the Paediatric Endocrinology Unit at Ain Shams University and Chair of European Society for Paediatric Endocrinology (ESPE) Education and Training Committee, said. 'Growth hormone plays a critical role in effective treatment plans, but ensuring its availability has been a challenge in recent years. This challenge is being addressed through ongoing efforts to secure sufficient quantities to ensure uninterrupted treatment until puberty is complete. Treatment continuity, along with proper follow-up with a specialized physician, is essential for achieving optimal results,' Dr. Tarif added. This new concentration is being made available, expanding treatment options in line with the latest global scientific standards. This will allow for a better patient response in the treatment journey by minimizing interruptions. Securing the reliable availability of this human growth hormone reinforces medical efforts to provide comprehensive care for children and reflects the Egyptian medical community's commitment to delivering advanced treatment solutions for patients in need. 'The Egyptian government, within the context of the Egypt Vision 2030, has shown strong commitment to reducing the prevalence of short stature among children, aiming to improve public health for current and future generations, and help build a healthier, more productive workforce, in line with the national vision for sustainable development,' Sameh Elbagoury, Sandoz Egypt Country Head, said. 'Our top priority at Sandoz is to develop affordable biosimilars for high-quality biologics and ensure that as many patients as possible have access to them. Introducing the 15 mg concentration of our well-established Omnitrope growth hormone allows us to help local authorities meet the increase in demand for growth hormones, reflecting the positive impact and notable success achieved by the Presidential Initiative for the Early Detection of Anaemia, Obesity and Short Stature,' Elbagoury added.
Middle East
2 days ago
- Middle East
OPEN// TV BRICS: Malaysia accelerates AI-based healthcare reform as 156 clinics adopt cloud systems and digital records expand
KUALA LUMPUR, July 18 (MENA) - Malaysia's Ministry of Health has equipped 156 public health clinics with a cloud-based content management system (CCMS), enabling 70 percent of patients to receive treatment in under 30 minutes, TV BRICS reported. The move forms part of the country's broader digital transformation in healthcare, led by Health Minister Dzulkefly Ahmad. The minister reiterated the country's commitment to advancing cross-border digital capacity building, ethical AI governance, and regional health data cooperation. "Precision public health is no longer a future concept. It is already being implemented in Malaysia and will serve as a cornerstone for a resilient and competitive health system," said Dzulkefly. According to the ministry, the upgrade is a milestone in the artificial intelligence (AI)-driven reform program currently being rolled out nationwide. The officials stated that the first phase of the Electronic Medical Record (EMR) system has been successfully completed. This initial phase has processed five million prescriptions, 20 million vaccination entries, and one million dental records. (MENA) R R N/
